JBN Biotech ApS: Financial statements 2021
CVR: 40685693
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
JBN Biotech ApS (CVR 40685693) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -16,000 and a net result of DKK 4,337,323 compared with DKK -646,053 the year before. Equity in the 2021 report amounted to DKK 3,731,270. The solvency ratio was 12.3%.
- Gross Profit
- DKK -16,000
- Profit/Loss
- DKK 4,337,323
- Equity
- DKK 3,731,270
- Total Assets
- DKK 30,247,343
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -16 t. | 4.3 mio. | 3.7 mio. | 0 |
| 2020 | - | -27 t. | -646 t. | -606 t. | 0 |
Official annual report
Find more companies like JBN Biotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout JBN Biotech ApS
JBN Biotech ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jens Bredal Nielsen. The company is owned by Jens Bredal Nielsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -22,188 and a net result of DKK -222,807 compared with DKK -263,330 the year before. Equity in the 2025 report amounted to DKK 34,941,304.